We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TPC:NYSETutor Perini Corporation Analysis

Data as of 2026-06-12 - not real-time

$73.61

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Tutor Perini (TPC) is trading at $73.61, just below its 20‑day SMA of $74.05 but above the 200‑day SMA of $72.36, indicating a short‑term pull‑back within a longer‑term uptrend. The RSI sits at 45.7, suggesting neutral momentum, while the MACD histogram turned slightly positive (0.027) and the MACD line marginally crossed above its signal, delivering a modest bullish signal. Volatility is elevated at roughly 70% over the past 30 days and beta exceeds 1.7, pointing to a stock that moves sharply with market swings. Fundamentals show a trailing P/E of 50.4 versus an industry average of 30.4, and a DCF‑derived fair value of $273, highlighting a substantial valuation gap. However, the company posted 11.5% revenue growth, a forward EPS of $6.02 (up from $1.46 trailing), and a robust $19.8 B backlog, indicating strong growth prospects. Recent news notes a new $81.8 M contract and mixed earnings reactions, with some analysts upgrading on backlog quality while others caution on margin pressure.
The dividend yield is modest at 0.33% with an 8% payout ratio, suggesting sustainability, and the balance sheet is solid with a debt‑to‑equity of 36.8%. Given the high valuation, elevated volatility, and cyclical industry exposure, the stock presents a nuanced risk‑reward profile: upside potential if growth materializes but downside risk from overvaluation and market sensitivity.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price near immediate support at $68.61
  • Neutral technical indicators (RSI, MACD)
  • Recent earnings disappointment

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Strong $19.8 B backlog and new $81.8 M contract
  • Forward EPS growth and lower forward P/E (~12x)
  • Persistently high valuation relative to peers

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Sustained revenue growth and expanding margin potential
  • Low dividend payout supporting reinvestment
  • DCF fair value indicating significant upside

Key Metrics & Analysis

Financial Health

Revenue Growth11.50%
Profit Margin1.37%
P/E Ratio50.4
ROE11.40%
ROA2.97%
Debt/Equity36.84
P/B Ratio3.2
Op. Cash Flow$872.1M
Free Cash Flow$665.9M
Industry P/E30.4

Technical Analysis

TrendNeutral
RSI45.7
Support$68.61
Resistance$84.00
MA 20$74.05
MA 50$80.68
MA 200$72.36
MACDBullish
VolumeStable
Fear & Greed Index86.91

Valuation

Fair Value$273.20
Target Price$113.25
Upside/Downside53.85%
GradeOvervalued
TypeGrowth
Dividend Yield0.33%

Risk Assessment

Beta1.71
Volatility69.63%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.